Evusheld drug approved for use in people aged 12 and older who are immunocompromised or for whom COVID-19 vaccination is not recommended.
Health Canada has authorized a drug developed by AstraZeneca to prevent COVID-19 infections.
Evusheld has been cleared for people aged 12 and older who have a compromised immune system and are unlikely to get an adequate response to a COVID-19 vaccination, or for whom COVID-19 vaccination is not recommended.
The medication contains lab-made antibodies designed to remain in the body for months, which officials say will contain the virus if there is an infection.
The therapy has also been authorized in the United States and has been recommended by the European Medicines Agency.
Canadians Fingerprinted for Longer Term Stays
NRP Officers Commended by Chief
Woman's Body Found in Park
NRP Warn of Financial Institution Scam
MPP Demands Local Workers for Skyway
MPP Calls Out "Gov't Meddling"
Port Colborne Considers Growth Plan
Man Arrested in St. Catharines Home